You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 483 Initial safety results and immune responses induced by a novel human papillomavirus (HPV)-specific gorilla adenovirus immunotherapy vaccine, PRGN-2009, in patients with advanced HPV-associated cancers

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
483 Initial safety results and immune responses induced by a novel human papillomavirus (HPV)-specific gorilla adenovirus immunotherapy vaccine, PRGN-2009, in patients with advanced HPV-associated cancers
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to March 2024

AbstractFullPdf
Nov 2021487092
Dec 2021109011
Jan 2022196016
Feb 202214605
Mar 2022272014
Apr 2022124016
May 202280012
Jun 20225808
Jul 20227305
Aug 20227006
Sep 20225808
Oct 202210407
Nov 20224809
Dec 20224806
Jan 202382013
Feb 202364010
Mar 202380010
Apr 202360011
May 2023106011
Jun 202372011
Jul 202376014
Aug 202378012
Sep 20234604
Oct 20235404
Nov 20238609
Dec 20237008
Jan 202434010
Feb 202450010
Mar 202482057
Total29130409